Australia's largest stock trading and investment forum Australia's #1 stock forum

BLT

Click for more information

0.00%

2.6¢ benitec biopharma limited

“Comprehensive Analysis of the Immuno-Oncology Landscape,

First 3 Last

Share
Profile

Follow
scout41

536 Posts.

1

08/12/17

03:37

Post #: 29471189
Share

Originally posted by scout41 ↑

Looks like David Suhy focusing on a bolton strategy is the right move for CAR-T

"Would fit into GILD's stated strategy: With the company less focused on additional
transformational deals at the moment and recently applying greater emphasis on bolstering
their new cell therapy platform through, as management has noted, potential interest and bolton’s
such as cell switching or gene-editing, we believe that Cell Design Labs fits well into GILD’s
approach."

Expand

“Comprehensive Analysis of the Immuno-Oncology Landscape,

BLT Price at posting: 20.5¢ Sentiment: Hold Disclosure: Held
Upvote

Reply

Top Stories

Making money: How many microcaps should be in an investor's portfolio?

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

First 3 Last

Add BLT (ASX) to my watchlist